January 19, 2018 / 7:27 AM / 5 months ago

BRIEF-Orphazyme Granted Rare Pediatric Disease Designation By FDA

Jan 19 (Reuters) - ORPHAZYME A/S:

* REG-ARIMOCLOMOL FOR NPC RECEIVES RARE PEDIATRIC DISEASE DESIGNATION

* ORPHAZYME A/S - ARIMOCLOMOL HAS BEEN GRANTED RARE PEDIATRIC DISEASE DESIGNATION BY US FOOD AND DRUG ADMINISTRATION

* ORPHAZYME A/S - ARIMOCLOMOL FOR TREATMENT OF NIEMANN-PICK DISEASE TYPE C (NPC). Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below